Wockhardt Company Profile
What is the competitive landscape for WOCKHARDT
WOCKHARDT has seventy-six approved drugs.
There are seven US patents protecting WOCKHARDT drugs. There are three tentative approvals on WOCKHARDT drugs.
Summary for Wockhardt
| US Patents: | 7 |
| Tradenames: | 57 |
| Ingredients: | 54 |
| NDAs: | 76 |
| Patent Litigation for Wockhardt: | See patent lawsuits for Wockhardt |
| PTAB Cases with Wockhardt as petitioner: | See PTAB cases with Wockhardt as petitioner |
Drugs and US Patents for Wockhardt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wockhardt Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 075208-001 | Dec 17, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wockhardt Bio Ag | ZAYNICH | cefepime hydrochloride; zidebactam | POWDER;INTRAVENOUS | 220787-001 | May 29, 2026 | RX | Yes | Yes | 9,132,133 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wockhardt Bio Ag | LINDANE | lindane | LOTION;TOPICAL | 088190-001 | Aug 16, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wockhardt Ltd | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 077677-002 | Mar 16, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Wockhardt Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2904079 | ⤷ Start Trial |
| Brazil | 112015021393 | ⤷ Start Trial |
| Russian Federation | 2702361 | ⤷ Start Trial |
| South Korea | 20150123319 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Wockhardt Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2236132 | 122015000006 | Germany | ⤷ Start Trial | PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718 |
| 1915993 | 300625 | Netherlands | ⤷ Start Trial | PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414 |
| 2316456 | 349 22-2017 | Slovakia | ⤷ Start Trial | PRODUCT NAME: KOMBINACIA NALTREXONU VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM A BUPROPIONU VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/14/988 20150330 |
| 1304992 | 2013/044 | Ireland | ⤷ Start Trial | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
